Beta-adrenergic receptor blocking drugs in the treatment of cardiac arrhythmias.
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000009:adverse effects; D004983:Ethanolamines / Q000494:pharmacology; D006327:Heart Block / Q000150:complications; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000150:complications; D010673:Pheochromocytoma / Q000150:complications; D011433:Propranolol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013610:Tachycardia / Q000188:drug therapy; D014693:Ventricular Fibrillation / Q000188:drug therapy; D014927:Wolff-Parkinson-White Syndrome / Q000188:drug therapy
D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D004983:Ethanolamines; D011433:Propranolol